Concepedia
Statistics
Publications
10
Citations
1.2K
H-Index
Active since
1998
Affiliations
Pfizer (France)(Current)
Pfizer (United States)
Memorial Sloan Kettering Cancer Center
Pfizer (Italy)
München Klinik
Lucile Serfass is an author at Pfizer (France) specializing in medicine, oncology, and cancer pharmacology.
Publications per year
1998–2024
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis
Mai Nguyen, Richard Marcellus, Anne Roulston et al. · Proceedings of the National Academy of Sciences · 2007 · 652 citations · Full text
Medicine, Oncology, Pharmacology +17
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results
Robert J. Motzer, Alain Ravaud, Jean‐Jacques Patard et al. · European Urology · 2017 · 223 citations · Full text
Medicine, Oncology, Pharmacology +10
Annexin-I expression modulates drug resistance in tumor cells
Ying Wang, Lucile Serfass, Marie‐Odile Roy et al. · Biochemical and Biophysical Research Communications · 2004 · 73 citations
Medicine, Cancer Biology, Oncology +10
Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
Stephen J. Freedland, Rickard Sandin, Janvi Sah et al. · Cancer Medicine · 2021 · 55 citations · Full text
Medicine, Oncology, Urology +15
Effect of Heme Oxygenase Inhibitors on Soluble Guanylyl Cyclase Activity
Lucile Serfass, Judith N. Burstyn · Archives of Biochemistry and Biophysics · 1998 · 54 citations
Life Sciences, Biochemistry, Pharmacology +11
1–5 of 10